Strides Pharma Science has received an approval from the shareholders for divestment of Australian Business and for Transactions/ Contracts/ Arrangements with Solara Active Pharma Sciences up to Rs 500 crore in each financial year, commencing from FY 2018-19.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
